Journal article
Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure
Abstract
BACKGROUND: Diabetes is a risk factor for heart failure, and both conditions are increasing. Identifying treatments that prevent both conditions will be clinically important. We previously reported that candesartan (an angiotensin receptor blocker) reduces cardiovascular mortality and heart failure hospitalizations in heart failure patients (CHARM: Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity Program).
METHODS …
Authors
Yusuf S; Ostergren JB; Gerstein HC; Pfeffer MA; Swedberg K; Granger CB; Olofsson B; Probstfield J; McMurray JV
Journal
Circulation, Vol. 112, No. 1, pp. 48–53
Publisher
Wolters Kluwer
Publication Date
July 5, 2005
DOI
10.1161/circulationaha.104.528166
ISSN
0009-7322